EPCAM and neoplasm: In tumor cells, the dynamic expression of EpCAM correlates with the EMT and the reverse mesenchymal–epithelial transition (MET) processes since it is transiently lost during the early phase and subsequently re-acquired in metastatic niches [88], thus limiting the detection of epithelial–mesenchymal transitioned CTCs [89,90].